moz

MOZ-IN-2 is an protein MOZ inhibitor(IC50 of 125 μM).

WM-8014 (MOZ-IN-3) is an inhibitor of MOZ(IC50=55 nM), a member of histone acetyltransferases.

MOZ-IN-3 (Compound 6j), a potent KAT6A (MOZ) acetyltransferase inhibitor with an IC50 of 30 nM, exhibits antitumor activity against multiple myeloid leukemia cell lines, including HL-60, U937, SKNO-1, and K562. This compound also demonstrates favorable metabolic stability and pharmacokinetics [1].

Temozolomide (TMZ) is a DNA alkylating agent with blood-brain barrier permeability and oral activity. Temozolomide has antitumor activity and antiangiogenic activity, and also induces apoptosis and autophagy. Temozolomide is stable under acidic conditions and hydrolyzes under neutral or slightly alkaline conditions.

Clopimozide (R-29764) acts as a calcium channel antagonist and inhibits [3H] nilandipine binding.Clopimozide is a novel and orally available long-acting antischizophrenic psychostatic compound.

Osemozotan HCl (Osemozotan hydrochloride) is a novel and selective 5-HT1A receptor agonist that reduces methamphetamine-induced c-Fos expression in the medial prefrontal cortex and striatum.Osemozotan HCl is used in the study of mechanical abnormalities of pain and depression.

Sardomozide dihydrochloride (CGP 48664 dihydrochloride) is an inhibitor of S-adenosylmethionine decarboxylase (SAMDC, IC50 = 5 nM).

Osemozotan Free Base is a 5-HT(1A) receptor agonist.

Temozolomide Acid (TMZA) is a metabolite of temozolomide (TMZ). Temozolomide processes anticancer activity in vitro. Temozolomide (TMZ) is an oral alkylating agent used to treat glioblastoma multiforme (GBM) and astrocytomas.

Sardomozide is an inhibitor of S-adenosylmethionine decarboxylase (SAMDC)(IC50 of 5 nM).

Pimozide D4 is a deuterium labeled Pimozide.

Neflumozide (HRP 913) is an orally effective derivative of benzisoxazole, characterized by its potent dopamine antagonist properties and antipsychotic activity. It is utilized in research related to psychiatric disorders.

Mozenavir (DMP 450) is an orally active and highly selective inhibitor of HIV-1 protease with a Ki of 0.3 nM. It disrupts the cleavage and processing of viral polyproteins, thereby inhibiting the replication and maturation of HIV-1. Mozenavir shows potential for research into HIV infections.

Mozavaptan is a vasopressin receptor antagonist.

Pimozide (R6238) is a diphenylbutylpiperidine derivative and a dopamine antagonist with the antipsychotic property. Pimozide selectively inhibits type 2 dopaminergic receptors in the central nervous system (CNS), thereby decreasing dopamine neurotransmission and reducing the occurrence of the motor and vocal tics and delusions of parasitosis. In addition, this agent antagonizes alpha-adrenergic and 5-HT2 receptors.

Axamozide is a biochemical.

Chromozym PK is a chromogenic substrate for factor XII assay.

Chromozym-TH HCl can act on it to liberate p-nitroaniline (yellow color).

Chromozym U can be used as a chromogenic substrate test for urokinase in Shigella.

2-NP-AMOZ is a 2-nitrophenyl derivative of AMOZ, a metabolite of the antibiotic Furaltadone, serving as a reliable tool for protein-bound AMOZ detection.

Mozavaptan (OPC-31260) is a competitive antagonist of vasopressin receptors, targeting both V1 and V2 receptors, with IC50 values of 1.2 μM and 14 nM, respectively.

AMOZ has a wide range of applications in life science related research.

Mozistobart is a humanized IgG1κ antibody that targets CD22, with HumanIgG1kappa, Isotype Control serving as its corresponding isotype control.

2-NP-AMOZ-d5 is a deuterated compound of 2-NP-AMOZ. 2-NP-AMOZ has a CAS number of 183193-59-1. 2-NP-AMOZ is a 2-nitrophenyl derivative of AMOZ, which is a metabolite of the antibiotic Furaltadone. This chemical compound specifically serves as a reliable tool for protein bound AMOZ detection.